Meeting
2014 ASCO Annual Meeting
Comparison of prostate health index and PCA3 values in patients with clinical or biologic suspicion of prostate cancer.
Authors
Pierre-Jean Lamy
Institut Régional du Cancer Montpellier, Montpellier, France
Pierre-Jean Lamy , Benoit Leizour , Florence Castan , Frederic Montels , Anne-Claire Laberenne , Sylvie Roques , Didier Ayuso , Vincent Abd El Fattah , Samer Abdel-Hamid , Antoine Faix , Bruno Segui , David Azria , Xavier Rebillard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 5055)
DOI
10.1200/jco.2014.32.15_suppl.5055
Abstract #
5055
Poster Bd #
184
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
The predictive value of DRE in the modern era of prostate cancer diagnostics.
First Author: Joel Marcus Andersson
Poster
2016 Genitourinary Cancers Symposium
Utility of PCA3 and TMPRSS2:ERG urinary biomarkers in African American men undergoing prostate biopsy.
First Author: Allison H. Feibus
Poster
2024 ASCO Genitourinary Cancers Symposium
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.
First Author: Ekamjit Singh Deol
Poster
2024 ASCO Genitourinary Cancers Symposium
i-Biomarker CaDx: A circulating miRNA-based multi-cancer detection tool with explainable AI for prostate cancer.
First Author: Alexandru George Floares